Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Treprostinil in PH-HFpEF
NCT03037580Phase 3Terminated
- Sponsor
- United Therapeutics Corporation
- Start
- Aug 2017
- Primary completion
- Dec 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of treprostinil in pulmonary hypertension (PH), sponsored by United Therapeutics Corporation. Started Aug 2017; status: terminated.
02
Drugs
treprostinil
03
Conditions
pulmonary hypertension (PH)
Beyond the preview
Go deeper on NCT03037580.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03037580.